BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29031499)

  • 1. MicroRNAs 15A and 16-1 Activate Signaling Pathways That Mediate Chemotaxis of Immune Regulatory B cells to Colorectal Tumors.
    Liu R; Lu Z; Gu J; Liu J; Huang E; Liu X; Wang L; Yang J; Deng Y; Qian J; Luo F; Wang Z; Zhang H; Jiang X; Zhang D; Qian J; Liu G; Zhu H; Qian Y; Liu Z; Chu Y
    Gastroenterology; 2018 Feb; 154(3):637-651.e7. PubMed ID: 29031499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.
    Liu S; Sun X; Wang M; Hou Y; Zhan Y; Jiang Y; Liu Z; Cao X; Chen P; Liu Z; Chen X; Tao Y; Xu C; Mao J; Cheng C; Li C; Hu Y; Wang L; Chin YE; Shi Y; Siebenlist U; Zhang X
    Gastroenterology; 2014 Oct; 147(4):847-859.e11. PubMed ID: 24931456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
    Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
    Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
    Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
    Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
    Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
    Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
    Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
    J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.
    Li ZW; Sun B; Gong T; Guo S; Zhang J; Wang J; Sugawara A; Jiang M; Yan J; Gurary A; Zheng X; Gao B; Xiao SY; Chen W; Ma C; Farrar C; Zhu C; Chan OTM; Xin C; Winnicki A; Winnicki J; Tang M; Park R; Winnicki M; Diener K; Wang Z; Liu Q; Chu CH; Arter ZL; Yue P; Alpert L; Hui GS; Fei P; Turkson J; Yang W; Wu G; Tao A; Ramos JW; Moisyadi S; Holcombe RF; Jia W; Birnbaumer L; Zhou X; Chu WM
    Gastroenterology; 2019 Jun; 156(8):2297-2312. PubMed ID: 30836096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
    Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
    Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.
    Öner MG; Rokavec M; Kaller M; Bouznad N; Horst D; Kirchner T; Hermeking H
    Gastroenterology; 2018 Dec; 155(6):1868-1882. PubMed ID: 30099074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
    Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
    Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment.
    Lu Y; Li Y; Liu Q; Tian N; Du P; Zhu F; Han Y; Liu X; Liu X; Peng X; Wang X; Wu Y; Tong L; Li Y; Zhu Y; Wu L; Zhang P; Xu Y; Chen H; Li B; Tong X
    Gastroenterology; 2021 Aug; 161(2):575-591.e16. PubMed ID: 33901495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
    Rigby RJ; Simmons JG; Greenhalgh CJ; Alexander WS; Lund PK
    Oncogene; 2007 Jul; 26(33):4833-41. PubMed ID: 17297444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑16 inhibits interleukin‑13‑induced inflammatory cytokine secretion and mucus production in nasal epithelial cells by suppressing the IκB kinase β/nuclear factor‑κB pathway.
    Gao Y; Yu Z
    Mol Med Rep; 2018 Oct; 18(4):4042-4050. PubMed ID: 30132525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells.
    Rizzo A; De Mare V; Rocchi C; Stolfi C; Colantoni A; Neurath MF; Macdonald TT; Pallone F; Monteleone G; Fantini MC
    Carcinogenesis; 2014 Jul; 35(7):1536-46. PubMed ID: 24480808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
    Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
    Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.